Tuesday, 16 August 2022

Covishield vaccine dose gap extends to 12-16 weeks

13 May 2021 | News

It is based on the available real-life evidences, particularly from the UK

Image credit- shutterstock.com

Image credit- shutterstock.com

The COVID Working Group chaired by Dr N K Arora, Director, INCLEN Trust, has recommended extension of the gap between the first and second doses of COVISHIELD vaccine to 12-16 weeks. The present gap between the two doses of COVISHIELD vaccine is 6-8 weeks.

Based on the available real-life evidences, particularly from the UK, the COVID-19 Working Group agreed for increasing the dosing interval to 12-16 weeks between two doses of COVISHIELD vaccine. No change in interval of COVAXIN vaccine doses was recommended.

The COVID Working Group comprises of the following members:

  1. Dr N K Arora- Director, INCLEN Trust (an international network of healthcare professionals)
  2. Dr Rakesh Agarwal, Director and dean, GIPMER, Puducherry
  3. Dr Gagandeep Kang, professor, Christian Medical College, Vellore
  4. Dr J P Mulliyal, Retd professor, Christian Medical College, Vellore
  5. Dr Naveen Khanna, Group Leader, International Centre For Genetic Engineering And Biotechnology  (ICGEB), JNU, New Delhi
  6. Dr Amulya Panda, Director, National Institute of Immunology, New Delhi
  7. Dr V G Somani, Drugs Controller General of India (DCGI), Govt of India

The recommendation of the COVID Working Group was accepted by the National Expert Group on Vaccine Administration for Covid-19 (NEGVAC), headed by Dr V K Paul, Member (Health) Niti Aayog in its meeting on 12th May 2021.

The Union Ministry of Health and Family Welfare has also accepted this recommendation of the COVID Working Group for extension of the gap between the first and second doses of COVISHIELD vaccine to 12 -16 weeks.

Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account